SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-116353
Filing Date
2023-11-09
Accepted
2023-11-09 16:56:56
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2330323d1_s3.htm S-3 270054
2 EXHIBIT 5.1 tm2330323d1_ex5-1.htm EX-5.1 7330
3 EXHIBIT 5.2 tm2330323d1_ex5-2.htm EX-5.2 8474
4 EXHIBIT 23.1 tm2330323d1_ex23-1.htm EX-23.1 3407
5 EX-FILING FEES tm2330323d1_exfilingfees.htm EX-FILING FEES 24108
6 GRAPHIC tm2330323d1_ex5-1img001.jpg GRAPHIC 32522
7 GRAPHIC tm2330323d1_s3-img01.jpg GRAPHIC 7102
8 GRAPHIC tm2330323d1_s3-img02.jpg GRAPHIC 9291
  Complete submission text file 0001104659-23-116353.txt   382478
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275452 | Film No.: 231393498
SIC: 2836 Biological Products, (No Diagnostic Substances)